RUNX2 and familial pancreatic carcinoma: Recently, we have demonstrated that RUNX2 prohibits GEM-mediated cell death of p53-null pancreatic cancer AsPC-1 cells as well as p53-mutated pancreatic cancer Panc-1 cells through down-regulation of TAp63-dependent cell death pathway [24, 41].